Viatris, Theravance Biopharma Study in China Shows Efficacy, Safety of COPD Treatment – November 13, 2023 5:53 pm

Viatris Inc. (Viatris) is a global healthcare company. The company’s divisions are Developed Markets, Greater China, JANZ and Emerging Markets. The Developed Markets segment has operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ division has operations in Japan, Australia and New Zealand. The Emerging Markets segment includes developing markets and emerging economies in more than 125 countries and the company’s ARV franchise. The portfolio includes more than 1,400 approved molecules across several key therapeutic areas, including leading brands and complex generics. The company has around 40 manufacturing sites worldwide. Its products include Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen Auto Injector, Fraxiparine and Yupelri.